A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Sulfamethazine
Canrenone
The risk or severity of adverse effects can be increased when Canrenone is combined with Sodium phosphate, monobasic, unspecified form.
Sulfamethazine
Isosorbide
The risk or severity of adverse effects can be increased when Isosorbide is combined with Sodium phosphate, monobasic, unspecified form.
Sulfamethazine
Mersalyl
The risk or severity of adverse effects can be increased when Mersalyl is combined with Sodium phosphate, monobasic, unspecified form.
Sulfamethazine
Efonidipine
The risk or severity of adverse effects can be increased when Efonidipine is combined with Sodium phosphate, monobasic, unspecified form.
Sulfamethazine
Potassium citrate
The risk or severity of adverse effects can be increased when Potassium citrate is combined with Sodium phosphate, monobasic, unspecified form.
Sulfamethazine
Canrenoic acid
The risk or severity of adverse effects can be increased when Canrenoic acid is combined with Sodium phosphate, monobasic, unspecified form.
Sulfamethazine
Azosemide
The risk or severity of adverse effects can be increased when Azosemide is combined with Sodium phosphate, monobasic, unspecified form.
Sulfamethazine
Indisulam
The risk or severity of adverse effects can be increased when Indisulam is combined with Sodium phosphate, monobasic, unspecified form.
Sulfamethazine
Ularitide
The risk or severity of adverse effects can be increased when Ularitide is combined with Sodium phosphate, monobasic, unspecified form.
Sulfamethazine
Tienilic acid
The risk or severity of adverse effects can be increased when Tienilic acid is combined with Sodium phosphate, monobasic, unspecified form.
Sulfamethazine
Piretanide
The risk or severity of adverse effects can be increased when Piretanide is combined with Sodium phosphate, monobasic, unspecified form.
Sulfamethazine
Chlorphenoxamine
The therapeutic efficacy of Sodium phosphate, monobasic, unspecified form can be decreased when used in combination with Chlorphenoxamine.
Sulfamethazine
Timepidium
The therapeutic efficacy of Sodium phosphate, monobasic, unspecified form can be decreased when used in combination with Timepidium.
Sulfamethazine
Pipenzolate
The therapeutic efficacy of Sodium phosphate, monobasic, unspecified form can be decreased when used in combination with Pipenzolate.
Sulfamethazine
Emetonium iodide
The therapeutic efficacy of Sodium phosphate, monobasic, unspecified form can be decreased when used in combination with Emetonium iodide.
Sulfamethazine
Fenpiverinium
The therapeutic efficacy of Sodium phosphate, monobasic, unspecified form can be decreased when used in combination with Fenpiverinium.
Sulfamethazine
Camylofin
The therapeutic efficacy of Sodium phosphate, monobasic, unspecified form can be decreased when used in combination with Camylofin.
Sulfamethazine
Diphemanil
The therapeutic efficacy of Sodium phosphate, monobasic, unspecified form can be decreased when used in combination with Diphemanil.
Sulfamethazine
Penthienate
The therapeutic efficacy of Sodium phosphate, monobasic, unspecified form can be decreased when used in combination with Penthienate.
Sulfamethazine
Dihexyverine
The therapeutic efficacy of Sodium phosphate, monobasic, unspecified form can be decreased when used in combination with Dihexyverine.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3